Faith-Build Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.12 Cr
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -37.77%
- Profit Growth -9.06%
- Ebitda 33.23%
- Net Worth -10.38%
- Total Assets -4.39%
About Faith-Build Pharmaceuticals
Faith-Build Pharmaceuticals Private Limited (FPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 2007 and has a history of 17 years and ten months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Balasaheb Waghmare, Swaraj Patil, Sunil Ukalkar, and Three other members serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2007PTC169637
-
Company No.
169637
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Faith-Build Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Patil
|
Managing Director | 04-Apr-2007 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Swaraj Patil
|
Director | 01-Sep-2021 | Current |
|
Balasaheb Waghmare
|
Director | 04-Apr-2007 | Current |
|
Sunil Ukalkar
|
Whole-Time Director | 21-Nov-2013 | Current |
|
Krishna Deshpande
|
Whole-Time Director | 21-Nov-2013 | Current |
|
Surekha Patil
|
Director | 01-Apr-2009 | Current |
Financial Performance of Faith-Build Pharmaceuticals.
Faith-Build Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 37.77% decrease. The company also saw a slight decrease in profitability, with a 9.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Faith-Build Pharmaceuticals?
In 2020, Faith-Build Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Faith-Build Constructions Private LimitedSurekha Patil and Rajendra Patil are mutual person
-
Shreeanand Associates Llp
Rajendra Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Faith-Build Pharmaceuticals?
Unlock and access historical data on people associated with Faith-Build Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Faith-Build Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Faith-Build Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
